BGI
B Group Inc Portfolio holdings
AUM
$116M
This Quarter Return
-6.51%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$106M
AUM Growth
–
Cap. Flow
+$106M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
97.55%
Holding
17
New
15
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
ADMA Biologics
ADMA
|
$39.2M |
| 2 |
Insmed
INSM
|
$24.2M |
| 3 |
Zai Lab
ZLAB
|
$10.5M |
| 4 |
Iovance Biotherapeutics
IOVA
|
$7.34M |
| 5 |
Akero Therapeutics
AKRO
|
$7.23M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
ADMA Biologics
ADMA
$4.12B
| $39.2M | 23.98% |
+2,287,542
| New | +$39.2M |
|
|
2
Insmed
INSM
$28.8B
| $24.2M | 14.77% |
+350,000
| New | +$24.2M |
|
|
3
Zai Lab
ZLAB
$3.68B
| $10.5M | 6.4% |
+400,000
| New | +$10.5M |
|
|
4
Iovance Biotherapeutics
IOVA
$807M
| $7.34M | 4.49% |
+992,000
| New | +$7.34M |
|
|
5
Akero Therapeutics
AKRO
$3.74B
| $7.23M | 4.42% |
+260,000
| New | +$7.23M |
|
|
CLLS
6
Cellectis
CLLS
$258M
| $5.55M | 3.39% |
+3,081,501
| New | +$5.55M |
|
7
Aura Biosciences
AURA
$389M
| $3.88M | 2.37% |
+472,576
| New | +$3.88M |
|
8
Sight Sciences
SGHT
$213M
| $2.29M | 1.4% |
+629,370
| New | +$2.29M |
|
9
Taysha Gene Therapies
TSHA
$797M
| $1.67M | 1.02% |
+965,556
| New | +$1.67M |
|
10
Spyre Therapeutics
SYRE
$996M
| $1.16M | 0.71% |
+50,000
| New | +$1.16M |
|
11
Assembly Biosciences
ASMB
$190M
| $799K | 0.49% |
+50,651
| New | +$799K |
|
12
Apogee Therapeutics
APGE
$2.17B
| $680K | 0.42% |
+15,000
| New | +$680K |
|
13
BioNTech
BNTX
$24B
| $399K | 0.24% |
+3,500
| New | +$399K |
|
|
ORKA
14
Oruka Therapeutics, Inc. Common Stock
ORKA
$554M
| $388K | 0.24% |
+20,000
| New | +$388K |
|
15
Ultragenyx Pharmaceutical
RARE
$2.89B
| $320K | 0.2% |
+7,596
| New | +$320K |
|
16
Corvus Pharmaceuticals
CRVS
$428M
| – | – |
0
| – | – |
|
17
Invesco QQQ Trust
QQQ
$364B
| – | – |
0
| – | – |
|